Refine
Has Fulltext
- yes (31)
Is part of the Bibliography
- yes (31)
Year of publication
Document Type
- Journal article (30)
- Doctoral Thesis (1)
Keywords
- Virologie (11)
- measles virus (5)
- sphingomyelinase (4)
- Immunologie (3)
- Masernvirus (3)
- SARS-CoV-2 (3)
- ceramides (3)
- Biologie (2)
- T cell receptors (2)
- T cells (2)
- dendritic cell (2)
- flow cytometry (2)
- 3D tissue model (1)
- ATP-adenosine triphosphate (1)
- CNS infection (1)
- Dendritische Zelle (1)
- Escherichia coli infections (1)
- HIV (1)
- Immunbiologie (1)
- LFA-1 (1)
- MV receptor (1)
- MV transcription (1)
- Masern (1)
- Medicine (1)
- Medizin (1)
- Mitochondria (1)
- Neisseria meningitidis (1)
- Ratte (1)
- Seahorse XF (1)
- T cell (1)
- T cell migration (1)
- T cell receptor (1)
- T cell silencing (1)
- TCR signaling cascade (1)
- Zentralnervensystem (1)
- acid sphingomyelinase (1)
- actins (1)
- activation (1)
- adhesion (1)
- alternative splicing (1)
- azido-ceramides (1)
- bacterial pathogens (1)
- cell cycle and cell division (1)
- cell membrane (1)
- cell migration (1)
- cell staining (1)
- ceramidase (1)
- ceramide (1)
- cytoskeleton (1)
- endothelial cells (1)
- enzymes (1)
- fluoxetine (1)
- gene regulation (1)
- genetic interference (1)
- glycosphingolipids (1)
- immunosuppression (1)
- measles (1)
- meningococcal disease (1)
- motility (1)
- neutral sphingomyelinase (1)
- neutral sphingomyelinase-2 (1)
- oxidative phosphorylation (1)
- polarization (1)
- reverse transcriptase-polymerase chain reaction (1)
- small interfering RNAs (1)
- sphingolipids (1)
- sphingosine 1-phosphate (1)
- sphingosine-1-phosphate (1)
- tyrosine (1)
- unwindase (1)
Recently, we have shown that C6-ceramides efficiently suppress viral replication by trapping the virus in lysosomes. Here, we use antiviral assays to evaluate a synthetic ceramide derivative α-NH2-ω-N3-C6-ceramide (AKS461) and to confirm the biological activity of C6-ceramides inhibiting SARS-CoV-2. Click-labeling with a fluorophore demonstrated that AKS461 accumulates in lysosomes. Previously, it has been shown that suppression of SARS-CoV-2 replication can be cell-type specific. Thus, AKS461 inhibited SARS-CoV-2 replication in Huh-7, Vero, and Calu-3 cells up to 2.5 orders of magnitude. The results were confirmed by CoronaFISH, indicating that AKS461 acts comparable to the unmodified C6-ceramide. Thus, AKS461 serves as a tool to study ceramide-associated cellular and viral pathways, such as SARS-CoV-2 infections, and it helped to identify lysosomes as the central organelle of C6-ceramides to inhibit viral replication.